Optical molecular imaging developer ART Advanced Research Technologies reported higher sales for its fiscal 2005 second quarter (end-June 30), but the company's net loss also continued.
ART had second-quarter sales of $752,000 (U.S.), up sharply compared with the $190,000 reported for the same period last year. For the quarter, the Montreal-based firm posted a net loss of $2.701 million, almost even when compared with a net loss of $2.694 million a year ago.
The continuation of net losses was attributed to R&D expenditures related to clinical trial preparation, ART said.
By AuntMinnie.com staff writers
August 4, 2005
Related Reading
ART raises $5 million, July 29, 2005
ART scores $5.9 million investment, July 12, 2005
ART sales up, but loss grows, May 9, 2005
GE, ART sell SAMI to Novartis, October 21, 2003
GE, ART alliance notch first sale, September 23, 2003
Copyright © 2005 AuntMinnie.com
